HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Michel Komajda Selected Research

irbesartan

9/2015Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
8/2015Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
7/2015Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
6/2015Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
6/2015The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
1/2015International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
11/2014History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
11/2014A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.
9/2014Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.
7/2014Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Michel Komajda Research Topics

Disease

81Heart Failure
12/2015 - 01/2002
18Systolic Heart Failure
12/2015 - 07/2003
8Myocardial Infarction
12/2015 - 02/2005
8Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/2014 - 10/2002
7Atrial Fibrillation
04/2015 - 07/2005
5Stroke (Strokes)
12/2015 - 02/2005
5Bradycardia
05/2015 - 09/2010
5Sudden Death
09/2011 - 05/2002
4Hypertension (High Blood Pressure)
12/2015 - 01/2008
3Left Ventricular Dysfunction
12/2015 - 02/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
07/2015 - 03/2010
3Cardiomyopathies (Cardiomyopathy)
05/2015 - 03/2007
2Diabetes Mellitus
12/2015 - 01/2011
2Bundle-Branch Block (Fascicular Block)
04/2015 - 09/2013
2Hemorrhage
06/2013 - 05/2013
2Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
07/2009 - 12/2003
2Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)
02/2008 - 10/2002
2Shock
06/2007 - 02/2005
2Muscular Diseases (Myopathy)
05/2006 - 05/2003
1Peripheral Arterial Disease
12/2015
1Chronic Obstructive Pulmonary Disease (COPD)
12/2015
1Anemia
12/2015
1Coronary Disease (Coronary Heart Disease)
10/2015
1Fatigue
03/2015
1Inflammation
04/2014
1Mood Disorders (Mood Disorder)
06/2013
1Malnutrition
06/2013
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
01/2013
1Hypotension (Low Blood Pressure)
12/2012
1Fibrosis (Cirrhosis)
09/2011
1Hypertrophy
09/2009
1Dyspnea (Shortness of Breath)
02/2009
1Human Influenza (Influenza)
03/2007
1Unstable Angina
03/2007
1Respiratory Sounds (Crackle)
12/2005

Drug/Important Bio-Agent (IBA)

25ivabradineIBA
12/2015 - 01/2010
20irbesartanFDA LinkGeneric
09/2015 - 10/2005
15carvedilol (Coreg)FDA LinkGeneric
01/2015 - 06/2002
13Metoprolol (Lopressor)FDA LinkGeneric
01/2015 - 06/2002
12Brain Natriuretic Peptide (Natrecor)FDA Link
08/2015 - 10/2003
10Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2015 - 07/2003
6pro-brain natriuretic peptide (1-76)IBA
08/2015 - 03/2009
6Angiotensin Receptor AntagonistsIBA
01/2015 - 01/2002
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2010 - 06/2002
5Carbon MonoxideIBA
12/2015 - 01/2008
5rosuvastatin (Crestor)FDA Link
01/2015 - 11/2007
5rosiglitazone (Avandia)FDA Link
08/2013 - 07/2007
4CreatinineIBA
04/2015 - 05/2006
3candesartanIBA
09/2015 - 12/2006
3Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2015 - 06/2012
3Spironolactone (Aldactone)FDA LinkGeneric
02/2010 - 08/2005
3DiureticsIBA
02/2010 - 07/2003
3Losartan (Cozaar)FDA LinkGeneric
11/2009 - 01/2002
3Proteins (Proteins, Gene)IBA
09/2009 - 02/2008
3Biological Markers (Surrogate Marker)IBA
03/2009 - 05/2005
3Lamin Type A (Lamin A)IBA
05/2006 - 05/2003
2CholesterolIBA
04/2015 - 03/2007
2AngiotensinsIBA
09/2014 - 12/2012
2bipiperidyl mustard (BPM)IBA
07/2014 - 01/2013
2AnticoagulantsIBA
06/2013 - 05/2013
2SodiumIBA
10/2012 - 03/2010
2Natriuretic PeptidesIBA
09/2011 - 03/2009
2Angiotensin IIIBA
09/2008 - 01/2002
2Ventricular MyosinsIBA
04/2005 - 12/2003
1Desmoplakins (Desmoplakin)IBA
05/2015
1Carrier Proteins (Binding Protein)IBA
05/2015
1Myosins (Myosin)IBA
05/2015
1ferric carboxymaltoseIBA
03/2015
1IronIBA
03/2015
1Prostaglandins A (PGA)IBA
03/2015
1nebivololFDA Link
01/2015
1Bisoprolol (Concor)FDA LinkGeneric
01/2015
1tilisololIBA
07/2014
1Metformin (Glucophage)FDA LinkGeneric
08/2013
1Anti-Arrhythmia AgentsIBA
05/2013
1gamma Catenin (Plakoglobin)IBA
01/2013
1Desmosomal CadherinsIBA
01/2013
1AldosteroneIBA
12/2012
1Galectin 3 (LGALS3)IBA
09/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2012
1Collagen Type III (Type III Collagen)IBA
09/2011
1OsteopontinIBA
09/2011
1CollagenIBA
09/2011
1Collagen Type I (Type I Collagen)IBA
09/2011
1coenzyme Q10 (CoQ10)IBA
10/2010
1ThiazolidinedionesIBA
04/2010
1Insulin (Novolin)FDA Link
04/2010
1EnoximoneIBA
12/2009
1Mutant Proteins (Protein, Mutant)IBA
09/2009
1Calmodulin (Calcium-Dependent Activator Protein)IBA
07/2009
1Glucose (Dextrose)FDA LinkGeneric
06/2009
1Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2009
1Amiodarone (Amiodarona)FDA LinkGeneric
06/2007
14- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA
04/2006
1Aldosterone AntagonistsIBA
12/2005
1Cardiac GlycosidesIBA
08/2005

Therapy/Procedure

6Heart Transplantation (Grafting, Heart)
04/2014 - 05/2002
1Transplantation (Transplant Recipients)
03/2010
1Homologous Transplantation (Allograft)
03/2010
1Intensive Care (Surgical Intensive Care)
01/2008